Charles J Meyers, a director at $EQIX, sold 80 shares of the company on 01-16-2026 for an estimated $64,012. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.5% of their shares of this class of stock. Following this trade, they now own 15,147 shares of this class of $EQIX stock.
$EQIX Insider Trading Activity
$EQIX insiders have traded $EQIX stock on the open market 134 times in the past 6 months. Of those trades, 0 have been purchases and 134 have been sales.
Here’s a breakdown of recent trading of $EQIX stock by insiders over the last 6 months:
- CHARLES J MEYERS has made 0 purchases and 22 sales selling 7,181 shares for an estimated $5,643,942.
- ADAIRE FOX-MARTIN (CEO and President) has made 0 purchases and 13 sales selling 5,564 shares for an estimated $4,262,677.
- KEITH D TAYLOR (Chief Financial Officer) has made 0 purchases and 7 sales selling 2,051 shares for an estimated $1,649,345.
- RAOUF ABDEL (EVP, Global Operations) has made 0 purchases and 15 sales selling 1,893 shares for an estimated $1,469,440.
- BRANDI GALVIN MORANDI (Chief People Officer) has made 0 purchases and 8 sales selling 1,433 shares for an estimated $1,156,114.
- JONATHAN LIN (Chief Business Officer) has made 0 purchases and 13 sales selling 1,012 shares for an estimated $802,861.
- KURT PLETCHER (Chief Legal Officer) has made 0 purchases and 30 sales selling 944 shares for an estimated $734,651.
- SIMON MILLER (Chief Accounting Officer) has made 0 purchases and 17 sales selling 561 shares for an estimated $427,931.
- MICHAEL SHANE PALADIN (Chief Customer & Rev Officer) has made 0 purchases and 7 sales selling 327 shares for an estimated $263,025.
- CHRISTOPHER B PAISLEY has made 0 purchases and 2 sales selling 125 shares for an estimated $97,491.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EQIX Hedge Fund Activity
We have seen 522 institutional investors add shares of $EQIX stock to their portfolio, and 580 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VALEO FINANCIAL ADVISORS, LLC removed 8,154,390 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,386,844,423
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,139,498 shares (+916.3%) to their portfolio in Q3 2025, for an estimated $1,675,740,413
- NOMURA HOLDINGS INC removed 896,945 shares (-77.9%) from their portfolio in Q3 2025, for an estimated $702,523,201
- SG AMERICAS SECURITIES, LLC added 716,618 shares (+377167.4%) to their portfolio in Q4 2025, for an estimated $549,044,046
- JPMORGAN CHASE & CO added 589,367 shares (+25.8%) to their portfolio in Q3 2025, for an estimated $461,615,809
- GOLDMAN SACHS GROUP INC added 387,849 shares (+42.8%) to their portfolio in Q3 2025, for an estimated $303,778,850
- AMUNDI removed 349,857 shares (-32.0%) from their portfolio in Q3 2025, for an estimated $274,021,996
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EQIX Revenue
$EQIX had revenues of $2.3B in Q3 2025. This is an increase of 5.22% from the same period in the prior year.
You can track EQIX financials on Quiver Quantitative's EQIX stock page.
$EQIX Congressional Stock Trading
Members of Congress have traded $EQIX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EQIX stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$EQIX Analyst Ratings
Wall Street analysts have issued reports on $EQIX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 12/03/2025
- Truist Securities issued a "Buy" rating on 11/18/2025
- TD Cowen issued a "Buy" rating on 10/30/2025
- JP Morgan issued a "Overweight" rating on 10/30/2025
- Morgan Stanley issued a "Overweight" rating on 10/16/2025
To track analyst ratings and price targets for $EQIX, check out Quiver Quantitative's $EQIX forecast page.
$EQIX Price Targets
Multiple analysts have issued price targets for $EQIX recently. We have seen 8 analysts offer price targets for $EQIX in the last 6 months, with a median target of $950.0.
Here are some recent targets:
- Maher Yaghi from Scotiabank set a target price of $959.0 on 01/14/2026
- Ari Klein from BMO Capital set a target price of $900.0 on 12/03/2025
- Anthony Hau from Truist Securities set a target price of $973.0 on 11/18/2025
- Richard Choe from JP Morgan set a target price of $950.0 on 10/30/2025
- Michael Elias from TD Cowen set a target price of $995.0 on 10/30/2025
- Cameron McVeigh from Morgan Stanley set a target price of $950.0 on 10/16/2025
- Brendan Lynch from Barclays set a target price of $804.0 on 08/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
